Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[30 years experience with haloperidol].

B Bandelow1, P Müller, E Rüther

  • 1Psychiatrische Universitätsklinik Göttingen.

Fortschritte Der Neurologie-Psychiatrie
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2022
Same author

[Pharmacotherapy of anxiety disorders-Guideline-conform treatment and new developments].

Der Nervenarzt·2021
Same author

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2020
Same author

Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial.

The journal of prevention of Alzheimer's disease·2018
Same author

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study.

European archives of psychiatry and clinical neuroscience·2018
Same author

[Erratum to: Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders. How many personnel are need?]

Der Nervenarzt·2017
Same journal

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Haloperidol, a widely used neuroleptic, offers significant antipsychotic benefits with moderate sedation and mild side effects. This review covers 30 years of research on its pharmacodynamics, pharmacokinetics, and clinical applications.

Area of Science:

  • Psychopharmacology
  • Neuroscience

Context:

  • Haloperidol, a butyrophenone derivative, has been a cornerstone in psychiatric treatment for three decades.
  • It is frequently prescribed for diverse psychiatric and neurological conditions.

Purpose:

  • To comprehensively review 30 years of scientific literature on Haloperidol.
  • To consolidate data on its efficacy, safety, and clinical use.

Summary:

  • Haloperidol exhibits potent antipsychotic properties with moderate sedative and minimal vegetative side effects.
  • The review encompasses pharmacodynamics, pharmacokinetics, indications, adverse effects, drug interactions, dosage, contraindications, and precautions.

Impact:

  • Provides a foundational resource for understanding Haloperidol's role in neuroleptic therapy.

Related Experiment Videos

  • Informs ongoing and future research in neuroleptic drug development and clinical practice.